Page 153 - Industry News

GST hike on E&P: Govt chalking out plan to compensate upstream oil firms

The oil ministry is considering a scheme to compensate upstream companies for higher costs after GST on E&P services rose to 18 per cent, raising concerns of stranded taxes

Govt eases GST price label rules, scraps mandatory advertisements

Businesses can skip re-stickering and use old stock until March 2026

Qualcomm looks to bring smart glasses into everyday view with India push

Priced near regular eyewear, market set to grow 400% in CY 2025

HNIs doubled in just 4 years, fuelling surge in luxury auto demand

India's millionaire households have nearly doubled to 8.7 lakh in four years, creating a runway for luxury car demand as wealth fuels aspirations and premium consumption

Bricks to continue under GST 2.0 special composition scheme at 12%

The GST Council has kept the special composition scheme for bricks unchanged, retaining 6% without ITC and 12% with ITC, with a Rs 20 lakh threshold, under GST 2.0

Govt picks 8 more startups to build indigenous LLMs, sectoral SLMs

Eight more startups, including Fractal Analytics and BharatGen, will build LLMs and SLMs under the IndiaAI Mission as the govt also plans 500 AI data labs and an AI governance framework

HSBC chiefs meet PM Modi, pledge long-term support for India's growth

HSBC Chairman Mark Tucker and CEO Georges Elhedery met Prime Minister Modi this week, reaffirming commitment to India's growth and support for key national programmes

BNP Paribas leases 1.45 lakh sq ft office space in Thane for ₹95 lakh

BNP Paribas has leased 1.45 lakh sq ft at Hiranandani Centaurus in Thane West for Rs 94.95 lakh monthly rent as BFSI sector demand drives office leasing growth in India

UP govt injects ₹140 crore to boost startups, innovation ecosystem

The state has set up a network of 72 incubators and seven centres of excellence (CoE) to catalyse startups, promote business culture and generate jobs for the youth

Domestic pharma firms expected to post 7-9% revenue growth in FY26: Icra

Revenue for the sample set of companies is projected to expand by 7-9% in FY2026, supported by 8-10% growth in the domestic market and 10-12% growth in Europe, Icra said

PM internship scheme pilot likely to be extended for two months

The launch of the full fledged scheme would be based on the feedback received from the stakeholder consultations and evaluation of outcomes during the implementation of the Pilot Project

US Automakers may soon hike car prices as tariff costs pressure profits

The average manufacturer's suggested retail price, or MSRP, on new vehicles in the US rose less than 1 per cent from mid-March to mid-August, according to car-shopping site Edmunds

Indian pharma faces US revenue slowdown amid scrutiny, tariffs: ICRA

ICRA projects Indian pharma firms' US revenue growth to slow due to price erosion, USFDA scrutiny and tariff risks, while high dependence on Chinese APIs persists despite PLI

Air India Express to launch direct Bengaluru-Bangkok flights from Oct 18

The airline already connects Bangkok with Lucknow, Pune, and Surat, and operates direct flights between Hyderabad and Phuket

Goa real estate, hotel tariffs see 15-20% correction amid tourist surge

The substantial correction in real estate rates across Goa is a trend that analysts believe is part of a 'healthy cycle' that would create stronger foundations for growth in the future

Govt has met industry needs, now India Inc must expand: Nirmala Sitharaman

Finance Minister Nirmala Sitharaman said the government has delivered reforms, urges companies to invest, expand production, and partner in skilling youth for India's growth

Indian industry must join journey toward developed nation: N Chandrasekaran

He also stressed the need to develop the entire ecosystem across all stakeholders

FMCG firms may shift to new GST regime without changing current price tag

The govt could allow discounts to be reflected in the invoice during the transition

Lupin gets USFDA nod for generic cancer drug Lenalidomide capsules

Lupin has received USFDA approval for generic Lenalidomide capsules in six strengths, adding to competition in the US oncology market for Bristol-Myers Squibb's Revlimid

BlackBuck to ditch Bengaluru's tech corridor over crumbling roads

Poor roads, traffic snarls and metro delays fuel frustration among tech firms and citizens